Methods of using truncated glial cell line-derived neurotrophic factor
US7390781B2 · kind B2 · utility
6Cited by
17References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 7, 2004 |
| Grant date | Jun 24, 2008 |
| Priority date | — |
| Expiry date | Jan 3, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are novel proteins, referred to as truncated glial cell line-derived neurotrophic factor (truncated GDNF) proteins, that promote dopamine uptake by dopaminergic cells and promote the survival of nerve cells. Also disclosed are processes for obtaining the truncated GDNF proteins by recombinant genetic engineering techniques.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.